Clinical trial
Pan-tumor MRD Study
NCT06605404
Study timeline
Study start (actual)2025-01-08Date precision: day
Registry last updated2026-09-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Esophageal Cancerunresolved
Melanoma (Skin Cancer)unresolved
NSCLC (Non-small Cell Lung Cancer)unresolved
Pancreatic (Exocrine Only)unresolved
Mix of Solid Tumors (MOST)unresolved
Interventions
blood and tissue samplesDIAGNOSTIC_TEST
Sponsors & collaborators
Paradigm Healthlead sponsor
Mapped research locations
San DiegoCalifornia, United States2HoustonTexas, United States1AtlantaGeorgia, United States1BirminghamAlabama, United States1PortlandOregon, United States1RochesterMinnesota, United States1CharlotteNorth Carolina, United States1RichmondVirginia, United States1LouisvilleKentucky, United States1Little RockArkansas, United States1LexingtonKentucky, United States1WichitaKansas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06605404 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.